Very early plasma cell differentiation
浆细胞极早期分化
基本信息
- 批准号:10157788
- 负责人:
- 金额:$ 7.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-25 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAffectAntibodiesB Cell ProliferationB cell differentiationB-Cell ActivationB-LymphocytesBiochemical PathwayCDC2 geneCell CycleCell divisionCell physiologyCyclin-Dependent Kinase InhibitorDevelopmentEndoplasmic Reticulum Degradation PathwayEventExpression ProfilingGene ChipsGene DeletionGene ExpressionGenerationsGenesGenetic TranscriptionImmune responseKineticsMessenger RNAMitosisModelingMolecular ChaperonesOrganellesPathway interactionsPatternPhosphotransferasesPlasma CellsProcessProtein SecretionProteinsProteomeProteomicsRaptorsRestRoleSignal TransductionStructureSystemTSC1 geneTestingTranscriptXBP1 geneactivating transcription factoradaptive immunitygene functionin vivoinhibitor/antagonistmRNA Expressionnovelplasma cell differentiationpredictive modelingprotein expressionresponsetranscription factortranscriptome sequencing
项目摘要
Abstract
The biochemical pathways through which activated B cells initiate antibody synthesis
and secretion while simultaneously undergoing cell division are unknown. Current
models predict that early plasma cells generate the organelle structures needed for
robust antibody secretion by activating the unfolded protein response (UPR) in response
to increased antibody synthesis and through a mitosis-dependent process. This project
centers on an alternative model where activated B cells prepare for plasma cell function
by enacting the UPR well before increased antibody synthesis and independently of
mitosis. Hence we propose that induction of the UPR in B cells is as much proactive as it
is reactive. We will test this new model while also dissecting the past observations that
marginal zone B cells generate plasma cells much faster than most B cells. We propose
three specific aims: 1) Define biochemical pathways coordinating very early PC
differentiation, 2) Define the role of constitutive mTORC1 signaling in MZ B cell
differentiation, and 3) Uncouple mitosis and early PC differentiation.
摘要
活化的B细胞启动抗体合成的生化途径
和分泌,同时进行细胞分裂是未知的。电流
模型预测,早期的浆细胞产生细胞器结构,
通过激活未折叠蛋白反应(UPR)来应答,
增加抗体的合成,并通过有丝分裂依赖的过程。这个项目
中心是另一种模型,其中活化的B细胞为浆细胞功能做准备
通过在增加抗体合成之前制定普遍定期审议,
分裂。因此,我们认为B细胞中UPR的诱导与它的作用一样积极。
是反应性的。我们将测试这个新模型,同时也剖析过去的观察,
边缘区B细胞比大多数B细胞更快地产生浆细胞。我们提出
三个具体目标:1)定义协调早期PC的生化途径
2)确定组成型mTORC 1信号在MZ B细胞中的作用
3)解偶联有丝分裂和早期PC分化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAIR ARGON其他文献
YAIR ARGON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAIR ARGON', 18)}}的其他基金
Exploring respiratory chain glycoproteomics in mitochondrial disease
探索线粒体疾病中的呼吸链糖蛋白组学
- 批准号:
9333395 - 财政年份:2015
- 资助金额:
$ 7.69万 - 项目类别:
Control of plasma cell longevity by the IRE1 pathway
IRE1 途径控制浆细胞寿命
- 批准号:
8976594 - 财政年份:2014
- 资助金额:
$ 7.69万 - 项目类别:
Regulation of insulin-like growth factors by the ER chaperone GRP94
ER 伴侣 GRP94 对胰岛素样生长因子的调节
- 批准号:
8075480 - 财政年份:2010
- 资助金额:
$ 7.69万 - 项目类别:
Regulation of insulin-like growth factors by the ER chaperone GRP94
ER 伴侣 GRP94 对胰岛素样生长因子的调节
- 批准号:
7898378 - 财政年份:2010
- 资助金额:
$ 7.69万 - 项目类别:
Regulation of insulin-like growth factors by the ER chaperone GRP94
ER 伴侣 GRP94 对胰岛素样生长因子的调节
- 批准号:
8322048 - 财政年份:2010
- 资助金额:
$ 7.69万 - 项目类别:
Regulation of insulin-like growth factors by the ER chaperone GRP94
ER 伴侣 GRP94 对胰岛素样生长因子的调节
- 批准号:
8469513 - 财政年份:2010
- 资助金额:
$ 7.69万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.69万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 7.69万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 7.69万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 7.69万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 7.69万 - 项目类别:
Standard Grant